With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in ...

Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.

Pfizer PFE COVID revenues have been declining due to lower demand. The company records direct sales and alliance revenues ...

There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.

Pfizer reported higher-than-expected profit on Tuesday due to strong sales of COVID-19 treatment Paxlovid, an important win ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

Unverified data about events after vaccinations is not evidence that the vaccine caused the event, as suggested in social ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Pfizer reported third-quarter revenue and adjusted profit that blew past expectations. The company hiked its full-year ...

Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...

Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...

Here's what they found. Pfizer-BioNTech: The Pfizer-BioNTech vaccine was the first COVID vaccine to receive FDA Emergency Use Authorization from the Food and Drug Administration back in December 2020.